You searched for Antibody candidate - Page 26 of 69

News and Trends 3 Aug 2022

AbCellera and Atlas Venture to collaborate on new company for therapeutic antibody discovery

…The collaboration leverages Atlas’ track record in forming innovative biotech companies, and AbCellera’s ability to quickly deliver lead drug candidates to bring transformational new medicines to patients faster. “AbCellera’s clinically…

August 3, 2022 - 2 minutesmins - By Jim Cornall

More News! 20 Jun 2017

Belgian Llama Antibody Developer gets Second Preclinical Milestone from Danish Pharma

…Pharma teamed up to develop antibodies to counter inflammatory diseases in a deal totalling €105M. argenx just received its second preclinical milestone for granting Leo access to its preclinical candidate,…

June 20, 2017 - 1 minutemin - By Evelyn Warner

Interview 9 Oct 2017

The Woman Developing the Next Generation of Cancer Immunotherapy

…so far and putting its unique antibody technology one step closer to patients. As she continues at Ganymed by supporting the new owners in their takeover of late-stage antibody development,…

October 9, 2017 - 8 minutesmins - By Clara Rodríguez Fernández

Best in Biotech 8 Mar 2017

Which European Blockbusters Topped the Charts in 2016?

…is a monoclonal antibody used to treat breast cancers, which are HER2–positive. The antibody binds to the HER2 receptor overexpressed on some breast cancers, thereby inhibiting the proliferation of these…

March 8, 2017 - 4 minutesmins - By Melanie De Almeida

News and Trends 6 Sep 2017

Tiziana‘s Antibody Formulation Enters Phase IIa Trial for Liver Disease Treatment

Tiziana makes moves towards a €37B market with an oral monoclonal antibody (mAb) formulation to treat non-alcoholic steatohepatitis (NASH) . Tiziana, which has previously developed compounds targeting the second most…

September 6, 2017 - 3 minutesmins - By Alex Dale

More News! 14 Dec 2017

New Biotech in Oxford Takes on Arthritis of the Spine

…for the trial, expected to start in the first half of 2018. Namilumab is a human antibody that targets granulocyte macrophage-colony stimulating factor (GM-CSF). The antibody was originally developed by…

December 14, 2017 - 2 minutesmins - By Clara Rodríguez Fernández

News and Trends 6 Dec 2022

Pictor receives $5M in funding for Covid antibody test and human and animal portfolios

…company announced it had received confirmation of CE registration for its PictArray SARS-CoV-2 IgG enzyme-linked immunosorbent assay (ELISA) antibody test as per in vitro diagnostic directive (IVDD) regulations. CE registration…

December 6, 2022 - 3 minutesmins - By Liza Laws

News and Trends 25 Mar 2016

Israeli Pharma gets FDA Approval for New Antibody against Severe Asthma

…This type is associated with more frequent symptoms and a higher risk of asthma attacks. Physiology of asthma (Source: Health Navigator New Zealand) Reslizumab is a monoclonal antibody that binds…

March 25, 2016 - 3 minutesmins - By Denise Neves Gameiro

glioblastoma oncolytic virus transgene 2

News and Trends 20 Sep 2022

Collaboration to develop new glioblastoma combination therapy nets €1.06M

…by Amsterdam UMC and will help CimCure to study passive immunization. Additionally, Covalab will develop full-length and antibody fragments, to be used for CAR-T cells. This novel approach to antibody…

September 20, 2022 - 4 minutesmins - By Jim Cornall

Interview 24 Jul 2018

Meet the Dutch Scientists who Invented Keytruda, “The President’s Drug”

…Aduro believes its drug candidate can be combined with immune checkpoint inhibitors to induce immunity. Hans van Eenennaam: Our lead antibody program, targeting the APRIL gene, a key driver in…

July 24, 2018 - 6 minutesmins - By Editorial Team

News and Trends 6 Apr 2020

UK Biotech’s Arthritis Drug Enters Study in Coronavirus Patients

…we can prevent or reduce deterioration in Covid-19 patients for which there are currently few treatments available.” Izana’s antibody therapy is a human monoclonal antibody targeting GM-CSF and is in…

April 6, 2020 - 2 minutesmins - By David Kirk

Interview 11 Sep 2017

Meet the CEO of Europe’s Largest & Most Fiercely Independent Biotech

…example, a bispecific antibody, we can do this in-house. We’ve been able to create two completely new next-generation antibody technology platforms, DuoBody and HexaBody for bispecific and immune effector function…

September 11, 2017 - 8 minutesmins - By Evelyn Warner

Knowledge hub

Categories

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Search Results for: Antibody candidate

AbCellera and Atlas Venture to collaborate on new company for therapeutic antibody discovery

Belgian Llama Antibody Developer gets Second Preclinical Milestone from Danish Pharma

The Woman Developing the Next Generation of Cancer Immunotherapy

Which European Blockbusters Topped the Charts in 2016?

Tiziana‘s Antibody Formulation Enters Phase IIa Trial for Liver Disease Treatment

New Biotech in Oxford Takes on Arthritis of the Spine

Pictor receives $5M in funding for Covid antibody test and human and animal portfolios

Israeli Pharma gets FDA Approval for New Antibody against Severe Asthma

Collaboration to develop new glioblastoma combination therapy nets €1.06M

Meet the Dutch Scientists who Invented Keytruda, “The President’s Drug”

UK Biotech’s Arthritis Drug Enters Study in Coronavirus Patients

Meet the CEO of Europe’s Largest & Most Fiercely Independent Biotech

Subscribe to our newsletter to get the latest biotech news!

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!